Bergman & Beving AB: Annual General Meeting of Bergman &

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
50
Bergman & Beving AB: Annual General Meeting of Bergman & Beving AB held 23 August 2018

Press release

Annual General Meeting of Bergman & Beving AB held 23 August 2018

At the Annual General Meeting and the ensuing statutory Board of Directors Meeting of Bergman & Beving AB today, resolutions passed included the following:

Determination of income statement and balance sheet

The Annual General Meeting approved the balance sheet and income statement as well as the consolidated income statement and consolidated balance sheet.

Dividend

The Annual General Meeting approved a dividend of SEK 2.50 per share. The record date for payment of the dividend was set as 27 August 2018. The dividend is expected to be distributed to shareholders by Euroclear Sweden AB on 30 august 2018.

Discharge the Board of Directors and the President from liability

The Annual General Meeting resolved to discharge the Board of Directors and the President from liability for the administration of the Company for the financial year from 1 April 2017 to 31 March 2018.

Board of Directors

The meeting approved the Election committee's proposal that the Board should consist of 6 regular directors.

The Meeting resolved to place SEK 1,975,000 at the disposal of the Board of Directors for the compensation of its members. The Compensation of the Board of Directors is allocated as follows: SEK 600,000 to the Chairman of the Board and SEK 275,000 to each of the other directors. Additionally, the Annual General Meeting resolved that the following additional fees will be paid for committee work: Compensation Committee - SEK 50,000 to each committee director, and Audit Committee - SEK 50,000 to the Chairman.

Directors shall be able to invoice their Board fees through a wholly owned Swedish company or private business if current tax legislation allows for invoicing and provided that the Company will not incur any expense. If a director invoices his/her Board fee through a wholly owned company or private business, the fee shall be augmented by an amount equivalent to the statutory social security contributions and value-added tax.

Audit fees shall be paid in accordance with approved invoices.

The current Directors Roger Bergqvist, Anders Börjesson, Henrik Hedelius, Malin Nordesjö, Johan Sjö and Louise Undén were re-elected.

Johan Sjö was elected as Chairman of the Board.

At the statutory Board meeting, the entire Board was appointed to serve as the Company's Audit Committee. The Chairman Johan Sjö was appointed as Chairman of the Audit Committee. The Chairman and the Director Malin Nordesjö were appointed to serve as the Company's Compensation Committee.

A presentation of the Board's Directors is available on the Company's website at www.bergmanbeving.com.

Auditors

The Annual General Meeting resolved to re-elect the registered accounting firm KPMG AB as the Company's auditors for the period ending with the adjournment of the 2019 Annual General Meeting. KPMG has appointed the Authorised Public Accountant Håkan Reising as Chief Auditor.

Guidelines for determining compensation and other terms of employment for the President & CEO and other members of Group management

The Annual General Meeting resolved to adopt the guidelines for determining compensation and other terms of employment for the President & CEO and other members of Group management as proposed by the Board of Directors.

Issuance of call options on repurchased shares and transfer of repurchased shares to executives

The Annual General Meeting resolved, in accordance with the Board of Directors' proposal, in deviation from the shareholders' preferential rights, to offer 16 senior executives in the Bergman & Beving Group the opportunity to acquire up to 210,000 call options for the Company's repurchased class B shares. These options will entitle the holders to acquire a corresponding number of shares during the period starting on 13 September 2021 and ending on 10 June 2022, equal to approximately 0.7 percent of the total number of shares and approximately 0.6 percent of the total number of votes in the Company. The options are to be acquired at market value. The acquisition price of the shares when exercising call options shall correspond to 120 percent of the volume-weighted average price paid for the Company's class B shares on the Nasdaq Stockholm during the period from 24 August 2018 to 7 September 2018, inclusive. In order to encourage participation in the share-based incentive programme ("the Programme), a subsidy equivalent to the premium paid for each call option shall be paid. The subsidy will be paid in September 2020 provided that the employment of the option holder with the Group has not been terminated or that the call options have not been divested before this date.

The costs of the Programme comprise the subsidy to be paid in September 2020 as above, and the social security fees that will accrue on this subsidy. The total cost of the subsidy, including social security fees, is estimated at MSEK 1.3 after corporate tax (based on the market conditions on 10 July 2018). Offsetting the subsidy is the option premium totalling approximately MSEK 1.3, which the Company will receive when transferring the call options, as a result of which the Programme does not entail any net charge to the Company's equity.

Acquisition and conveyance of treasury shares

The Annual General Meeting ("AGM") resolved in accordance with the Board's motion to authorise the Board, on one or more occasions during the period until the next AGM, to acquire and divest shares in the Company. The purpose of such repurchases is to be able to adapt the Group's capital structure and to pay for future acquisitions of businesses and operations using treasury shares. Holdings of treasury shares are also used to secure the Company's obligations under the share-based incentive programmes adopted at the 2017 and 2018 AGMs.

Acquisitions are to be carried out on Nasdaq Stockholm at a price that is within the registered price range at any given time, meaning the range between the highest purchase price and the lowest selling price. Acquisitions of own shares are limited so that the Company's total holding of treasury shares at no time exceeds 10 percent of the total number of shares in the Company.

Divestments of the Company's treasury shares may be carried out with or without preferential rights for shareholders, but may not be carried out on Nasdaq Stockholm. Divestments may be carried out to finance acquisitions of businesses or operations.

At the ensuing statutory Board meeting, the Board resolved to be able to exercise the mandate it had received from the AGM to repurchase shares in the Company.

Reduction of repurchased shares and increase of the share capital by way of bonus issue

The Meeting resolved to approve the board's proposal on reduction of 1,000,000 repurchased shares of series B and increase of the share capital by way of bonus issue.

Information about the Annual General Meeting

Further information about the Annual General Meeting is available on the Company's website under: Corporate governance/General Meetings of Shareholders.

Next report

The Interim Report for the period 1 April - 30 September 2018 (6 months) will be published on 26 October 2018.

Stockholm, 23 August 2018

Bergman & Beving AB (publ)

BOARD OF DIRECTORS

Contact information

Pontus Boman, President & CEO, Bergman & Beving AB, Tel: 010-454 77 00

Peter Schön, CFO, Bergman & Beving AB, Tel: +46 70 339 89 99   

The information in this document is such that Bergman & Beving AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 19:00 CET on 23 August 2018.

Bergman & Beving owns and refines companies that develop and market strong brands for professional users in industry and construction, mainly in the Nordic region, the Baltic States and Poland. Bergman & Beving aims to enable successful product companies to take the next step and become leading brands in their categories. The Group currently has some 15 brands, about 1,000 employees and revenue of approximately SEK 3.8 billion. Bergman & Beving is listed on Nasdaq Stockholm. Read more on the company's website: www.bergmanbeving.com.

Attachment

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Historic Records Set at 2026 CNO Monumental Marathon

Updated Category News Views 545

Race to Remember: Monumental Breakthroughs In the chilly November air of Indianapolis, the 2026 CNO Financial Indianapolis Monumental Marathon wasn't just another tick on the calendar—this was a banner day for running. With record-breaking performances across every distance, we saw what happens when a community of athletes, sponsors, and volunteers hits a perfect...

Continue Reading
Quantum Space Joins $185M NASA Lunar Transport Deal

Updated Category News Views 791

Quantum Space Bags a Chunk of NASA's Lunar Ambitions Alright, folks, buckle up because we're about to dive into the cosmos. Quantum Space just nabbed a sweet deal—a $185 million whopper of a contract from NASA's Moon Base Transportation program. This isn't chump change; it's a 25% slice for Quantum from the lot Arrow Science and Technology is heading. We're talking...

Continue Reading
TCL's Display Future: AI Meets Screens at DTC 2026

Updated Category News Views 526

Exploring New Horizons in Display Technology There's something brewing in Wuhan: a conference that’s shaping up like a tech enthusiast’s dream. This year, it's all about the symbiosis of cutting-edge tech and dazzling visuals as TCL CSOT gears up to unveil advancements at the Global Display Tech-Ecosystem Conference (DTC) 2026. If you're wondering whether this event...

Continue Reading
ASTS Faces Class Action; Investors Beware of Pitfalls

Updated Category News Views 112

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 129

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Amplifon Data Breach Spurs Legal Scrutiny for Millions

Updated Category News Views 188

Data Breach Fallout: Amplifon Under Fire When a big player like Amplifon gets hit with a data breach, it's like a wake-up call across the board. This one’s no small spill—over 1.3 million folks left wondering whether their personal information is fluttering around cyberspace for all who dare to peek. If you’ve missed the memo, Edelson Lechtzin LLP, the savvy cats in...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 190

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 138

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 40

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
Boston STEM Expo Sparks Young Minds in Engineering

Updated Category News Views 309

If you really want to light up a kid's imagination, throw them into a room full of science experiments and let 'em have at it. That's exactly what happened at the recent Society of Women Engineers' Innovation Expo in Boston's Seaport District. The place was buzzing, and not just because of all the engineering gadgets on display—it was the energy of young minds...

Continue Reading

Top 5 Most Recently Viewed Articles

Volvo Ends LiDAR Partnership: What This Means for LAZR Stock

Updated Category News Views 315

Volvo's Shift Away from LiDAR Technology Recently, the Swedish automaker Volvo announced its decision to cease its partnership with Luminar Technologies Inc. (NASDAQ: LAZR). This bold move has caught the attention of the automotive industry, especially those tracking advancements in autonomous vehicle technology. By not integrating LiDAR technology into its forthcoming...

Continue Reading
Samsung and Xiaomi Face Antitrust Findings in India Market

Updated Category News Views 157

Samsung and Xiaomi Face Antitrust Investigation in India Samsung, Xiaomi, and various other smartphone manufacturers are under serious scrutiny for allegedly colluding with major e-commerce platforms in India, undermining fair market practices. The Competition Commission of India (CCI) has gathered evidence that suggests these companies coordinated with Amazon and...

Continue Reading
Bonnie Navin Honored as Top 25 Medical Malpractice Attorney

Updated Category News Views 164

Bonnie Navin Attributes and Accolades Bonnie Navin of Rubenstein Law has recently earned a significant honor by being selected as a member of the Medical Malpractice Trial Lawyers Association - Top 25. This elite recognition is awarded to the most distinguished attorneys specializing in medical malpractice across the nation, and it showcases Navin's exceptional skill and...

Continue Reading
Top Dividend Stocks for Long-Term Passive Income Investors

Updated Category News Views 99

Success in the business world has never been a cakewalk. Many new ventures stumble within a decade, and only a handful manage to stay afloat while also boasting a robust and growing dividend program. Companies that consistently dish out dividends reflect financial health, but there’s more to the story. Take Abbott Laboratories (NYSE: ABT) and Johnson & Johnson (NYSE:...

Continue Reading
Cathie Wood Predicts Deflationary Boom Amid Market Decline

Updated Category News Views 404

Cathie Wood's Deflationary Boom Forecast Amid Market Turbulence CEO of Ark Funds, Cathie Wood, has made bold predictions regarding a potential "deflationary boom" despite significant losses in the stock market. Recent trading sessions saw renowned tech stocks, collectively known as the Magnificent Seven, lose about $780 billion in market capitalization in a single day,...

Continue Reading